Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-10-003047
Filing Date
2010-09-17
Accepted
2010-09-17 17:52:10
Documents
1
Period of Report
2010-09-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rdgdoc.html 4  
1 PRIMARY DOCUMENT rdgdoc.xml 4 2679
  Complete submission text file 0001437749-10-003047.txt   4687
Mailing Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612
Business Address 2301 DUPONT DRIVE, SUITE 525 IRVINE CA 92612 (949) 525-5471
AtheroNova Inc. (Issuer) CIK: 0001377053 (see all company filings)

EIN.: 201915083 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2237 HILLTOP LANE CAMARILLO CA 93012
Business Address
Zadini Giorgio C. (Reporting) CIK: 0001491350 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52315 | Film No.: 101079085